Loading
Patients on chemotherapy or immunotherapy answer a short weekly symptom questionnaire on their phone; severe answers alert the nurse the same day. Trials show this prolongs life.
Electronic patient-reported outcome monitoring with nurse alerts improved quality of life, reduced emergency visits and improved overall survival in a randomised trial at Memorial Sloan Kettering (Basch et al.) and in the PRO-TECT cluster-randomised trial in community practices. Uptake remains low because nobody is paid for the nursing time. The proposal is a reimbursed care standard: every patient on active systemic therapy is offered weekly ePRO monitoring with defined alert thresholds and response times, and payers cover the monitoring as they cover a drug.
Shares Basch: asking patients to report symptoms online during chemotherapy improved survival, Toxicity and quality of life are undervalued.
Shares Basch: asking patients to report symptoms online during chemotherapy improved survival, Toxicity and quality of life are undervalued.
Shares Patients lack understanding, navigation and agency, Toxicity and quality of life are undervalued.
Shares Patients lack understanding, navigation and agency, Toxicity and quality of life are undervalued.
Shares Patients lack understanding, navigation and agency, Memorial Sloan Kettering Cancer Center, Toxicity and quality of life are undervalued.
Shares Basch: asking patients to report symptoms online during chemotherapy improved survival, Toxicity and quality of life are undervalued.
Shares Patients lack understanding, navigation and agency, Toxicity and quality of life are undervalued.
Shares Patients lack understanding, navigation and agency, Toxicity and quality of life are undervalued.